119 related articles for article (PubMed ID: 26828024)
1. Inhibition by blueberries (bilberries) and extract from milk thistle of rat forestomach hyperplasia induced by oral smokeless tobacco (Swedish snus).
Nilsson R; Mićić M; Filipović J; Šobot AV; Drakulić D; Stanojlović M; Joksiċ G
Regul Toxicol Pharmacol; 2016 Apr; 76():94-101. PubMed ID: 26828024
[TBL] [Abstract][Full Text] [Related]
2. Activation of PI3K/Akt/NF-kB Signaling Mediates Swedish Snus Induced Proliferation and Apoptosis Evasion in the Rat Forestomach: Modulation by Blueberry.
Ranjani S; Kowshik J; Sophia J; Nivetha R; Baba AB; Veeravarmal V; Joksić G; Rutqvist LE; Nilsson R; Nagini S
Anticancer Agents Med Chem; 2020; 20(1):59-69. PubMed ID: 31696813
[TBL] [Abstract][Full Text] [Related]
3. Factors effecting the induction of rat forestomach hyperplasia induced by Swedish oral smokeless tobacco (snus).
Joksić G; Rutqvist LE; Mićić M; Tričković JF; Nilsson R
Regul Toxicol Pharmacol; 2019 Jun; 104():21-28. PubMed ID: 30844416
[TBL] [Abstract][Full Text] [Related]
4. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans.
Chlopcíková S; Psotová J; Miketová P; Simánek V
Phytother Res; 2004 Feb; 18(2):107-10. PubMed ID: 15022159
[TBL] [Abstract][Full Text] [Related]
5. Toxicological evaluation of smokeless tobacco: 2-year chronic toxicity and carcinogenicity feeding study in Wistar Han rats.
Theophilus EH; Hayes JR; Ayres PH; Morgan WT; Potts RJ; Garner CD; Fallacara DM; Hejtmancik MR; Singer AW
Exp Toxicol Pathol; 2015 Oct; 67(10):539-50. PubMed ID: 26382975
[TBL] [Abstract][Full Text] [Related]
6. Milk thistle.
Rainone F
Am Fam Physician; 2005 Oct; 72(7):1285-8. PubMed ID: 16225032
[TBL] [Abstract][Full Text] [Related]
7. Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.
Cufí S; Bonavia R; Vazquez-Martin A; Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Martin-Castillo B; Barrajón-Catalán E; Visa J; Segura-Carretero A; Bosch-Barrera J; Joven J; Micol V; Menendez JA
Food Chem Toxicol; 2013 Oct; 60():360-8. PubMed ID: 23916468
[TBL] [Abstract][Full Text] [Related]
8. Milk thistle (Silybum marianum (L.)Gaertn.): An overview about its pharmacology and medicinal uses with an emphasis on oral diseases.
Eita AAB
J Oral Biosci; 2022 Mar; 64(1):71-76. PubMed ID: 34968721
[TBL] [Abstract][Full Text] [Related]
9. Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats.
Vessal G; Akmali M; Najafi P; Moein MR; Sagheb MM
Ren Fail; 2010 Jul; 32(6):733-9. PubMed ID: 20540643
[TBL] [Abstract][Full Text] [Related]
10. Effect of Silymarin in Pdx-1 expression and the proliferation of pancreatic β-cells in a pancreatectomy model.
Soto C; Raya L; Juárez J; Pérez J; González I
Phytomedicine; 2014 Feb; 21(3):233-9. PubMed ID: 24176839
[TBL] [Abstract][Full Text] [Related]
11. Toxicology and carcinogenesis studies of milk thistle extract (CAS No. 84604-20-6) in F344/N rats and B6C3F1 mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2011 May; (565):1-177. PubMed ID: 21685957
[TBL] [Abstract][Full Text] [Related]
12. A silychristin isomer and variation of flavonolignan levels in milk thistle (Silybum marianum) fruits.
Smith WA; Lauren DR; Burgess EJ; Perry NB; Martin RJ
Planta Med; 2005 Sep; 71(9):877-80. PubMed ID: 16206045
[TBL] [Abstract][Full Text] [Related]
13. An updated systematic review of the pharmacology of silymarin.
Saller R; Melzer J; Reichling J; Brignoli R; Meier R
Forsch Komplementmed; 2007 Apr; 14(2):70-80. PubMed ID: 17464157
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of silymarin, a milk thistle (Silybium marianum) derivative on ethanol-induced oxidative stress in liver.
Das SK; Vasudevan DM
Indian J Biochem Biophys; 2006 Oct; 43(5):306-11. PubMed ID: 17133738
[TBL] [Abstract][Full Text] [Related]
15. In vivo efficacy study of milk thistle extract (ETHIS-094™) in STAM™ model of nonalcoholic steatohepatitis.
Pais P; D'Amato M
Drugs R D; 2014 Dec; 14(4):291-9. PubMed ID: 25404123
[TBL] [Abstract][Full Text] [Related]
16. New therapeutic potentials of milk thistle (Silybum marianum).
Milić N; Milosević N; Suvajdzić L; Zarkov M; Abenavoli L
Nat Prod Commun; 2013 Dec; 8(12):1801-10. PubMed ID: 24555302
[TBL] [Abstract][Full Text] [Related]
17. Milk thistle: Silybum marianum.
Pepping J
Am J Health Syst Pharm; 1999 Jun; 56(12):1195-7. PubMed ID: 10484652
[No Abstract] [Full Text] [Related]
18. Silymarin BIO-C, an extract from Silybum marianum fruits, induces hyperprolactinemia in intact female rats.
Capasso R; Aviello G; Capasso F; Savino F; Izzo AA; Lembo F; Borrelli F
Phytomedicine; 2009 Sep; 16(9):839-44. PubMed ID: 19303749
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a 72-hour repeated exposure to Swedish snus extract and total particulate matter from 3R4F cigarette smoke on gingival organotypic cultures.
Zanetti F; Sewer A; Titz B; Schlage WK; Iskandar AR; Kondylis A; Leroy P; Guedj E; Trivedi K; Elamin A; Martin F; Frentzel S; Ivanov NV; Peitsch MC; Hoeng J
Food Chem Toxicol; 2019 Mar; 125():252-270. PubMed ID: 30610935
[TBL] [Abstract][Full Text] [Related]
20. Anti- and pro-mutagenic effects of silymarin in the Ames bacterial reverse mutation assay.
Kaleeswaran S; Sriram P; Prabhu D; ; ; Mathuram LN
Phytother Res; 2009 Oct; 23(10):1378-84. PubMed ID: 19277970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
